Image

Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis

Validation of a Preclinical Model Based on Patient-derived Organoids for the Study of the Gut-joint Axis in Spondyloarthritis

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This project aims to develop and validate a model of human organoids derived from patients with Spondyloarthritis, focusing on synovial and intestinal tissues as targets of the gut-joint axis. The tissue marker profile of patient-derived organoids studied by gene expression, immunohistochemistry, and cytokine production profile will be compared with that of controls in order to test for the presence of specific biomarkers.

Eligibility

Inclusion Criteria:

  • More than 18 years of age;
  • Ability to understand and sign an informed consent form;
  • Clinical indication for intestinal and/or synovial biopsy;
  • Only for SpA patients group: meeting ASAS classification criteria.

Exclusion Criteria:

  • Actively treated cancer;
  • Severe comorbidities that, in the investigator's opinion, may affect the quality of samples for planned experimental applications;
  • Only for patients undergoing ileal-colic biopsy: history of colorectal cancer disease, celiac disease;
  • Only for patients undergoing a synovial biopsy: septic arthritis.

Study details
    Spondyloarthritis
    Inflammatory Bowel Diseases

NCT06421116

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

28 May 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.